Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation

Danielle Daley-Brown(Morehouse School of Medicine), Ruben R. Gonzalez‐Perez(Morehouse School of Medicine)
Disease Markers
January 1, 2017
10.1155/2017/8248175
Cited by 11

Related Papers

Leptin-Notch signaling axis is involved in pancreatic cancer progression
|Oncotarget|2016|71
Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer
|World Journal of Clinical Oncology|2017|24